Theravance Biopharma Inc. – Filings and Transcripts

NASDAQ: TBPH
Share price (5/21/26): $16.34
Market cap (5/21/26): $842 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Issuer tender offer – amended

Issuer tender offer – amended

Issuer tender offer – amended

Issuer tender offer – amended

Issuer tender offer – amended

Ownership Filter

Grimaud Brett A.

Winningham Rick E

News Filter

Reports First Quarter 2026 Financial Results and Provides Corporate Update

Financial Results and Provides Corporate Update

Reports Phase 3 CYPRESS Study Did Not Meet Primary Endpoint; Board Accelerates Strategic Review and Announces Cost Reduction Actions

Investor Presentation

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Confidential treatment order